 |
|
 |
Oramed Pharmaceuticals (OTC:ORMP.OB) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an oral insulin capsule currently in Phase 2 trials, the Company is seeking to revolutionize the treatment of diabetes.
|
Press Releases
May 16, 2011
Oramed Pharmaceuticals Granted Israeli Patent for its Core Technology in Oral Delivery of Proteins ... read more »
October 4, 2011
Corporate Profile's CPReports.com Publishes report by RAY DIRKS of RAY DIRKS Research on Oramed Pharmaceuticals ... read more »
May 8, 2012
Oramed Pharmaceuticals Awarded Grant by the Office of the Chief Scientist of Israel ... read more » |
| Press Center | Terms & Conditions | Privacy Statement | Design and programming by BIGDESIGN Creative Agency | All rights reserved © 2009 Oramed |